Browsing: Homepage Slider
In this review from Bioanalysis, the authors concisely introduce coated blade spray’s operational fundamentals and to consider how it correlates/contrasts with existing direct-to-MS technologies suitable for bioanalytical applications.
View time: 5 mins
In this first part of our first ‘In the lab’ series Scott Summerfield, Worldwide Head of Bioanalysis at GlaxoSmithKline (Ware, UK), talks through the basics of mass spectrometry.
Read time: 4:30 mins
In this column, Afshin Safavi differentiates between ‘assay qualification’ and ‘assay validation’ explaining current industry guidance, the translation of this guidance into the exploratory biomarker world, and how Bioagilytix (NC, USA) approaches these challenges.
View time: 7:05 mins
We had the opportunity to interview Shane Needham (Alturas Analytics; ID, USA) where he discusses how he co-founded the personalized CRO, Alturas Analytics.
To address questions raised in our Quantitative HRMS Spotlight and to investigate how the field has progressed over the last two years, key figures from pharma, CROs, biotech and academia share with us their experiences and thoughts on HRMS, giving our members a 360° opinion series.
In this month long feature, we bring you a collection of content focusing on the ‘hot topic’ of immuno-oncology.
If you are a supervisor wanting to highlight the work of someone in your team or are inspired by what your team are working on nominate now!
In late 2017 Bioanalysis and Bioanalysis Zone organized a panel discussion comprising of experts from leading CROs and pharmaceutical companies to converse about the latest topics in bioanalysis.
In this series of three panel discussions, key opinion leaders from both industries returned to partake in an open dialogue talking through the latest challenges the industry is facing and what changes they would like to see happen in the coming future.